Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses
about
A look at autoimmunity and inflammation in the eyeC-galactosylceramide: Synthesis and immunologyNK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT CellsAbnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS.Th1 and Th17 cells: adversaries and collaboratorsAlpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis.Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosisKLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells.Cytokines in autoimmune uveitis.Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory diseaseRegulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID).Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells.Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome.Invariant natural killer T cells: bridging innate and adaptive immunity.Natural killer T cells in health and disease.An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGDIL-6 promotes NK cell production of IL-17 during toxoplasmosis.Invariant NKT cells inhibit development of the Th17 lineage.AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 PathwaysAutoimmunity in the immune privileged eye: pathogenic and regulatory T cellsPreactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptorInterleukin-17 causes neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 miceInvariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.Invariant natural killer T cells in rheumatic disease: a joint dilemma.Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis.The Role of T Helper 17 Cells and Other IL-17-Producing Cells in Bone Resorption and Remodeling.Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity.
P2860
Q24623065-94B4B568-8841-4B1D-B7E6-8DE83A6CCAF0Q24625835-8720AABC-2E7A-45FF-9B46-D2A94462B068Q27308853-62CEAA83-055B-4412-82BD-5A617D561E1BQ27658388-75C64DC3-F584-46D9-BCFF-28676311EF46Q33988381-9C2EB5A8-5093-41A2-B6A3-42257491CD64Q34038557-03E2FAD6-67E5-4741-BDE3-3CA7F163CC52Q34172161-6C22B997-6D06-46E6-864F-619A7E08A75DQ34538700-4E81DCD9-A9EA-45A2-8B3E-5327B3D51DAFQ34790985-6A71A652-708C-43A2-A5D6-BA75E9034FCCQ34973712-5B8FD75D-F6D9-4876-BAEC-BCFF12D32EB2Q35294461-C0CDBF7E-DED6-4BE7-ADE8-70B577A3334BQ35572220-ACBE7AC4-91EE-4227-ACE3-D12FA0C1734EQ35744708-A9AC8D8A-6B96-40CC-B4A4-947D8901B314Q36280211-B7E1C23C-8B6F-49D3-BA60-96C8E9B6B1D2Q36338274-EAA0EA6B-E802-44E2-9A5A-5FCC2D7B45DBQ36739848-CF84FFBD-4C6D-42F9-8C86-F108063325B5Q36765720-BD9E843F-64C9-4CF3-A7D6-26B20653B3A8Q36797270-2638FD41-E454-49D5-A5F1-D97D31104EF3Q37132980-45AC2B51-860B-4D23-AB52-2D2C6E76D6E4Q37159061-3A97E320-0AC0-4478-A4E7-02D1CD00A58DQ37202385-E4EB1C9F-321A-49A5-A747-8F735417519DQ37217370-787A113C-DEBC-4AF4-B1B3-D13551AA3E62Q37297950-78BA131B-A4B7-41F0-B21F-9EADDC686FDDQ37350011-B2C66399-A2B3-4AC0-A915-840BF4D5B825Q37458940-38110C32-DA9E-4764-B7A4-AD357A3B329CQ37686081-FCA05CF6-75A1-4CFC-B298-FAE6931D273EQ37822744-07837E6C-863E-41F2-8A88-9899298EF202Q38199165-3631074D-6A3C-45A6-A07C-82F3A835E602Q38379550-0761D63B-8A90-4ED2-A8C6-0A25D461BA52Q42738957-B138B5E6-22B0-4D2C-B10C-E1268516F985Q42931110-0E0A094B-557F-468F-9EC4-295AD19E61BBQ49959102-19613D12-A119-43EE-9F6F-98860A4BD9ACQ55280646-DA04C65B-BDDA-4C27-89B1-A5E0909B5900
P2860
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of invariant NKT ce ...... daptive Th1 and Th17 responses
@en
Activation of invariant NKT ce ...... aptive Th1 and Th17 responses.
@nl
type
label
Activation of invariant NKT ce ...... daptive Th1 and Th17 responses
@en
Activation of invariant NKT ce ...... aptive Th1 and Th17 responses.
@nl
prefLabel
Activation of invariant NKT ce ...... daptive Th1 and Th17 responses
@en
Activation of invariant NKT ce ...... aptive Th1 and Th17 responses.
@nl
P2093
P2860
P50
P1476
Activation of invariant NKT ce ...... daptive Th1 and Th17 responses
@en
P2093
Anna M Hansen
Anne P Lawton
Moriya Tsuji
Phyllis B Silver
Rafael S Grajewski
Rajeev K Agarwal
Richard W Franck
Shao Bo Su
Stephane Sidobre
P2860
P304
P356
10.4049/JIMMUNOL.181.7.4791
P407
P577
2008-10-01T00:00:00Z